Avandia
is a drug approved to treat Type 2 diabetes. Safety data from recent studies
indicated a potentially significant increase in the risk of heart attack and
heart-related deaths on patients taking Avandia. Avandia was approved in 1999
for the treatment of Type 2 diabetes, a serious and life-threatening disease
that affects 18 to 20 million Americans. The FDA updated the product's label in
2006 to include a new warning about a potential increase in heart attacks and
heart-related chest pain in some individuals using Avandia. Avandia is
manufactured by GlaxoSmithKline, which is based in Research Triangle Park in
North Carolina.
Contact Us
Mark Davis, P.A. is now handling claims for individuals who have suffered a
heart attack or heart-related death while taking Avandia. Mark Davis, P.C.
is experienced in pharmaceutical product liability cases and settlements.
If you or a loved one has suffered a heart attack or heart-related death while
taking Avandia, please contact us at 1-800-277-0300, or send us an email at
info@markdavispc.com.